<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03913403</url>
  </required_header>
  <id_info>
    <org_study_id>1051075</org_study_id>
    <nct_id>NCT03913403</nct_id>
  </id_info>
  <brief_title>Study of Treatment's Echocardiographic Mechanisms</brief_title>
  <official_title>Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis: Study of Treatment's Echocardiographic Mechanisms (CLOVERS-STEM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intermountain Health Care, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wake Forest University Health Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Harborview Injury Prevention and Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Intermountain Health Care, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This ancillary study determines whether the Crystalloid Liberal or Vasopressors Early
      Resuscitation in Sepsis (CLOVERS) [ClinicalTrials.gov Identifier: NCT03434028] treatment arms
      (restrictive fluids strategy vs. liberal fluid strategy) for early sepsis-induced hypotension
      are associated with differences in cardiac structure and function based on an echocardiogram
      at 24 hours after randomization. Secondarily, this ancillary study explores possible
      heterogeneity of treatment effect based on an echocardiogram performed shortly after
      randomization in CLOVERS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis: Study of Treatment's
      Echocardiographic Mechanisms (CLOVERS-STEM) study is an ancillary study to CLOVERS, a parent
      multi-center, prospective, phase 3 randomized non-blinded interventional trial of fluid
      treatment strategies in the first 24 hours for patients with sepsis-induced hypotension. The
      CLOVERS trial attempts to determine the impact of a restrictive fluids strategy (vasopressors
      first followed by rescue fluids) as compared to a liberal fluid strategy (fluids first
      followed by rescue vasopressors) on 90-day in-hospital mortality in patients with
      sepsis-induced hypotension. This ancillary study obtains echocardiograms among
      CLOVERS-enrolled patients who consent to CLOVERS-STEM at baseline and 24 hours later
      (secondarily, this study also measures serum troponin levels at baseline and 24 hours) to
      pursue three aims: 1. Evaluate for differences in left ventricular global longitudinal strain
      at 24 hours after randomization between treatment arms; 2. Evaluate for differences in right
      ventricular end diastolic area to left ventricular end diastolic area ratio at 24 hours after
      randomization between treatment arms; 3. Explore possible heterogeneity of treatment effect
      based on baseline echocardiogram.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 30, 2019</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Left Ventricular Contractility at 24 hours</measure>
    <time_frame>24 +/- 6 Hours</time_frame>
    <description>Left Ventricular Global Longitudinal Strain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Right Ventricular Structure at 24 hours</measure>
    <time_frame>24 +/- 6 hours</time_frame>
    <description>Right Ventricular End Diastolic Area to Left Ventricular End Diastolic Area Ratio</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Day 3 delta SOFA</measure>
    <time_frame>at 72 hours</time_frame>
    <description>Difference between baseline and day 3 Sequential Organ Failure Assessment (SOFA) scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Right Ventricular Contractility at 24 hours</measure>
    <time_frame>24 +/- 6 hours</time_frame>
    <description>Right Ventricular Longitudinal Strain</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">210</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <description>Participants will receive 2 ECHO's and 2 Blood Draws</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ECHO</intervention_name>
    <description>Echocardiogram at baseline and 24 hours later</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood Draw</intervention_name>
    <description>Blood Draw for Troponin Levels - 5ml at baseline and 24 hours later</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants in the Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
        (CLOVERS) Trial with no allergy to ultrasound-enhancing agents
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Enrolled in the Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
             (CLOVERS) Trial

        Exclusion Criteria:

          -  Lack of Informed Consent for this Ancillary Study

          -  Allergy to Ultrasound-Enhancing Agents
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samuel Brown, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intermountain Health Care, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valerie Aston</last_name>
    <phone>801-507-4607</phone>
    <email>valerie.aston@imail.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carlos Barbagelata, MS</last_name>
    <phone>801-507-4607</phone>
    <email>carlos.barbagelata@imail.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Somnath Bose, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michelle Gong, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lane Smith, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health Sciences Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Akram Khan, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wesley Self, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Deepak Gupta, MD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel Brown, MD</last_name>
      <phone>801-507-6556</phone>
      <email>Samuel.brown@imail.org</email>
    </contact>
    <contact_backup>
      <last_name>Carlos Barbagelata, MS</last_name>
      <phone>801-507-4607</phone>
      <email>carlos.barbagelata@imail.org</email>
    </contact_backup>
    <investigator>
      <last_name>Samuel Brown, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sarah Beesley, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elliotte Hirshberg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Lanspa, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lindsay Leither</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harborview Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Catherine Hough, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Nicholas Johnson, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>April 10, 2019</study_first_submitted>
  <study_first_submitted_qc>April 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2019</study_first_posted>
  <last_update_submitted>June 19, 2019</last_update_submitted>
  <last_update_submitted_qc>June 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Fluid Management</keyword>
  <keyword>Sepsis-Induced Hypotension</keyword>
  <keyword>Vasopressors</keyword>
  <keyword>Cardiac Contractility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be collected electronically and stored at the Coordinating Center at Intermountain Medical Center. A de-identified version of the analytic data-set will be available for use 3 years after the primary publication. Data can be accessed at that point via the National Heart, Lung and Blood Institute (NHLBI) Biologic Specimen and Data Repositories Information Coordinating Center (BioLINCC) data repository.</ipd_description>
    <ipd_time_frame>A de-identified version of the analytic data-set will be available for use 3 years after the primary publication.</ipd_time_frame>
    <ipd_access_criteria>Investigators who complete the appropriate registrations with the Biologic Specimen and Data Repositories Information Coordinating Center (BioLINCC) will have access to the de-identified analytic dataset as per BioLINCC policies.</ipd_access_criteria>
    <ipd_url>https://biolincc.nhlbi.nih.gov/home/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

